Andere talen TRACON Pharmaceuticals, Inc.

Aandelen

TCON

US89237H3084

Geschatte realtime Cboe BZX Andere beurzen 20:50:23 30-04-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
1,73 ^USD	-7,72%		-5,95%	-50,31%

03/04	TRACON Pharmaceuticals geeft een update over de lopende ENVASARC Fase 2 Pivotal studie na de aanbeveling van het Independent Data Monitoring Committee om de studie volgens plan voort te zetten	CI
06/03	TRACON PHARMACEUTICALS, INC. : HC Wainwright handhaaft koopadvies	ZM

Andere talen

Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!

Gratis inschrijven

TRACON Pharmaceuticals Announces Reverse Stock Split	08/04
TRACON Pharmaceuticals Provides Update on Ongoing ENVASARC Phase 2 Pivotal Trial Following Independent Data Monitoring Committee Recommendation to Continue the Trial as Planned	03/04
TRACON Pharmaceuticals Provides Update on Ongoing ENVASARC Phase 2 Pivotal Trial Following Independent Data Monitoring Committee Recommendation to Continue the Trial as Planned	03/04
TRACON Pharmaceuticals, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	05/03
Tracon: Q4 Earnings Snapshot	05/03
Earnings Flash (TCON) TRACON PHARMACEUTICALS Reports Q4 Revenue $3M, vs. Street Est of $1.5M	05/03
TRACON Pharmaceuticals Reports Fourth Quarter and Year-End 2023 Financial Results and Provides Corporate Update	05/03
TRACON Pharmaceuticals, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	05/03
TRACON to Report Fourth Quarter and Year-End 2023 Financial Results and Provide Corporate Update on March 5, 2024	28/02
TRACON Pharmaceuticals Provides Positive Update on Ongoing ENVASARC Pivotal Phase 2 Trial	20/12
TRACON Pharmaceuticals, Inc. Provides Positive Update on Ongoing ENVASARC Pivotal Phase 2 Trial	20/12
Tracon Licenses Product Development Platform for $3 Million Upfront Payment; Shares Jump	20/11
TRACON Pharmaceuticals, Inc. Announces License of Product Development Platform for $3.0 Million Upfront Payment	20/11
TRACON Pharmaceuticals Announces License of Product Development Platform for $3.0 Million Upfront Payment	20/11
Wall Street Set to Open Slightly Higher as Investors Parse Powell Remarks	10/11
Exchange-Traded Funds, Equity Futures Rise After Fed Chief's Comments	10/11
Investors Parse Powell Remarks as US Futures Advance Slightly in Friday Trading	10/11
Top Premarket Gainers	10/11
TRACON Pharmaceuticals, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	09/11
Tracon: Q3 Earnings Snapshot	09/11

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen TRACON Pharmaceuticals, Inc.

Aandelen

TCON

US89237H3084

Andere talen

Filters